Danielle Colledge
5Patents
3h-index
6Co-inventors
42Inventor score
Filing activity: Jun 24, 2005 → Nov 26, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7745130B2 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US7384747B2 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7846663B2 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US8592143B2 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9702005B2 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.